Republished review: Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist

被引：0
|
作者：
Ware, James S. [1 ,2 ]
Roberts, Angharad M. [1 ]
Cook, Stuart A. [1 ,3 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England
[3] Royal Brompton & Harefield NHS Trust, Cardiovasc Biomed Res Unit, London, England
来源：
POSTGRADUATE MEDICAL JOURNAL | 2012年 / 88卷 / 1038期
基金：
英国惠康基金; 英国医学研究理事会;
关键词：
LONG-QT SYNDROME; NONINVASIVE PRENATAL-DIAGNOSIS; DILATED CARDIOMYOPATHY; FETAL DNA; CLOPIDOGREL; MUTATIONS; POLYMORPHISMS; GENOTYPE; EFFICACY; OUTCOMES;
D O I：
10.1136/pgmj.2011.300742rep
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The fast moving field of genomic medicine is already impacting on clinical care and cardiologists are fortunate to be in a position to benefit early from the transformative advances in genomics. However, the challenges associated with genomics in the clinic in general, and with next generation sequencing technologies in particular, are significant and cardiologists need to be prepared if they wish to surf the wave of genomic opportunity. This paper presents an overview of the implications of next generation sequencing for clinical diagnostics and personalised medicine in the cardiology clinic.
引用
收藏
页码：234 / 239
页数：6
相关论文
共 50 条
  • [1] Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist
    Ware, James S.
    Roberts, Angharad M.
    Cook, Stuart A.
    HEART, 2012, 98 (04) : 276 - 281
  • [2] Clinical implications of next-generation sequencing for cancer medicine
    Shuen, A.
    Foulkes, W. D.
    CURRENT ONCOLOGY, 2010, 17 (05) : 39 - 42
  • [3] Next-Generation Sequencing for Clinical Diagnostics
    Jacob, Howard J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (16): : 1557 - 1558
  • [4] Next-generation sequencing and empowering personalised cancer medicine
    McDermott, Ultan
    DRUG DISCOVERY TODAY, 2015, 20 (12) : 1470 - 1475
  • [5] Next-generation DNA sequencing in clinical diagnostics
    Lacoste, C.
    Fabre, A.
    Pecheux, C.
    Levy, N.
    Krahn, M.
    Malzac, P.
    Bonello-Palot, N.
    Badens, C.
    Bourgeois, P.
    ARCHIVES DE PEDIATRIE, 2017, 24 (04): : 373 - 383
  • [6] Next-Generation Sequencing in Diagnostics and Clinical Research
    Hoefler, Gerald
    PATHOBIOLOGY, 2017, 84 (06) : 289 - 291
  • [7] Next generation sequencing: implications in personalized medicine and pharmacogenomics
    Rabbani, Bahareh
    Nakaoka, Hirofumi
    Akhondzadeh, Shahin
    Tekin, Mustafa
    Mahdieh, Nejat
    MOLECULAR BIOSYSTEMS, 2016, 12 (06) : 1818 - 1830
  • [8] Review of Clinical Next-Generation Sequencing
    Yohe, Sophia
    Thyagarajan, Bharat
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (11) : 1544 - 1557
  • [9] Clinical Next Generation Sequencing for Precision Medicine in Cancer
    Dong, Ling
    Wang, Wanheng
    Li, Alvin
    Kansal, Rina
    Chen, Yuhan
    Chen, Hong
    Li, Xinmin
    CURRENT GENOMICS, 2015, 16 (04) : 253 - 263
  • [10] Regulatory variations in the era of next-generation sequencing: Implications for clinical molecular diagnostics
    Jarinova, Olga
    Ekker, Marc
    HUMAN MUTATION, 2012, 33 (07) : 1021 - 1030
12345